Who funds dengue research?
We count 51 funded dengue projects, active between 2020 and 2035, from 5 funders. The most came from Wellcome (26 projects), EU · MSCA (7 projects) and EU · Health (5 projects). The median award is $2.4M, across the 50 of 51 projects that list an amount.
- Funded projects
- 51
- Funders
- 5
- Median award
- $2.4M
- Open calls now
- 0
Top funders of dengue research
| Funder | Projects | Share | Median award |
|---|---|---|---|
| Wellcome | 26 | 51% | $3.8M |
| EU · MSCA | 7 | 14% | $290K |
| EU · Health | 5 | 10% | $9.2M |
| EU · ERC | 5 | 10% | $1.6M |
| EU · EIC | 1 | 2% | — |
| UKRI · MRC | 1 | 2% | — |
| UKRI · UKRI FLF | 1 | 2% | — |
| NSF · BIO | 1 | 2% | — |
| UKRI · BBSRC | 1 | 2% | — |
| NSF · GEO | 1 | 2% | — |
Projects whose title or summary mentions dengue. Median award: of the projects that list an amount, in US dollars; “—” when fewer than 3 do.
Open dengue funding calls
No open call mentions dengue in our listings today. We add new calls twice a day; create a free account to get an alert when one opens.
Funded dengue projects
A sample, latest start first, at most three per program.
-
Dengue Host–Virus Co-genomics: Genetic Interactions that Drive Disease Severity
Wellcome · £3,350,466 · ends 2035
-
Redefining how flaviviruses build infectious virions
Wellcome · £3,000,000 · ends 2034
-
CAREER: Regulation of female mating receptivity in Aedes aegypti mosquitoes
NSF · BIO · $1,645,075 · ends 2031
-
A randomised, adaptive phase 3 trial to evaluate host-directed therapeutics in patients hospitalised with moderate or severe dengue.
Wellcome · £8,747,548 · ends 2031
-
Tackling vector-borne diseases using Non-Replicating Virus Particles
UKRI · UKRI FLF · £1,888,722 · ends 2030
-
Scaling Health Interventions for Effective Long-term Dengue control (SHIELD): Implementation and policy research for scaling up Wolbachia in Indonesia
UKRI · MRC · £2,310,147 · ends 2030
-
CAREER: Mechanisms of Holocene Rainfall Change in the Northern Tropical Americas
NSF · GEO · $822,639 · ends 2030
-
Heritable, programmable anti-viral immunity in the dengue mosquito Aedes aegypti
UKRI · BBSRC · £839,851 · ends 2029
-
Achira Labs Pvt. Ltd. — Global Health and Development Public Awareness and Analysis
Gates Foundation · $461,725 · ends 2028
-
Collaborative Research: eMB: Math-model Informed Neural Network (MINN) based on Emerging Mathematics in Mosquito-Dengue Biology
NSF · MPS · $200,000 · ends 2028
How we count
Funded projects come from public award records (NIH RePORTER, NSF, EU CORDIS, UKRI Gateway to Research, Wellcome, the Gates Foundation, DOE, NASA and USDA NIFA) whose title or summary matches “dengue”. NIH lists each budget year separately; one project counts once. Amounts are as the funder lists them; medians use only projects that list one, in US dollars. Open calls and forecasts are from our listings of October 28, 2026. A project can mention a topic without being mainly about it, so treat the counts as a guide to who funds the area.
Get matched with dengue calls that fit your research
Build a free research profile and Lantern Grants scores every open call against your work, tracks your deadlines and reminds you before they pass.
Get matched free